Information:
Fel:
ID
35750
Beskrivning
Effects of Vildagliptin Versus Glibenclamide on Glycemia After Exercise in Patients With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01867502
Länk
https://clinicaltrials.gov/show/NCT01867502
Nyckelord
Versioner (1)
- 2019-03-20 2019-03-20 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
20 mars 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Diabetes Mellitus, Type 2 NCT01867502
Eligibility Diabetes Mellitus, Type 2 NCT01867502
- StudyEvent: Eligibility
Similar models
Eligibility Diabetes Mellitus, Type 2 NCT01867502
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Diabetes Mellitus, Non-Insulin-Dependent | Glucose measurement, fasting
Item
type 2 diabetes (fasting glucose ≥ 126 mg/dl or 7.0 mmol/l)(25);
boolean
C0011860 (UMLS CUI [1])
C0202045 (UMLS CUI [2])
C0202045 (UMLS CUI [2])
Hemoglobin A1c measurement
Item
recent hba1c determination (between 7, 5 and 10%);
boolean
C0474680 (UMLS CUI [1])
Absence Involvement with Exercise Regular
Item
not involved in regular physical exercise;
boolean
C0332197 (UMLS CUI [1,1])
C1314939 (UMLS CUI [1,2])
C0015259 (UMLS CUI [1,3])
C0205272 (UMLS CUI [1,4])
C1314939 (UMLS CUI [1,2])
C0015259 (UMLS CUI [1,3])
C0205272 (UMLS CUI [1,4])
Age
Item
older than 18 years;
boolean
C0001779 (UMLS CUI [1])
Metformin
Item
in use of metformin.
boolean
C0025598 (UMLS CUI [1])
Tobacco use | Analgesics | Anti-Inflammatory Agents
Item
smoker and use of analgesic or anti-inflammatory drugs during the week of the study
boolean
C0543414 (UMLS CUI [1])
C0002771 (UMLS CUI [2])
C0003209 (UMLS CUI [3])
C0002771 (UMLS CUI [2])
C0003209 (UMLS CUI [3])
Body mass index
Item
bmi > 40 kg/m²;
boolean
C1305855 (UMLS CUI [1])
Proliferative retinopathy
Item
proliferative retinopathy;
boolean
C0339467 (UMLS CUI [1])
Ischemic cardiomyopathy
Item
ischemic cardiomyopathy;
boolean
C0349782 (UMLS CUI [1])
Peripheral Vascular Disease
Item
peripheral vascular disease;
boolean
C0085096 (UMLS CUI [1])
Aspartate aminotransferase increased | Alanine aminotransferase increased
Item
blood aspartate transaminase (ast) and alanine transaminase (alt) 2.5 times higher the normal concentration before screening visit
boolean
C0151904 (UMLS CUI [1])
C0151905 (UMLS CUI [2])
C0151905 (UMLS CUI [2])
Lactose Intolerance
Item
lactose intolerance;
boolean
C0022951 (UMLS CUI [1])
Renal Insufficiency | Creatinine clearance measurement
Item
renal insufficiency (creatinine clearance <60ml/min);
boolean
C1565489 (UMLS CUI [1])
C0373595 (UMLS CUI [2])
C0373595 (UMLS CUI [2])
Blood pressure determination At rest | Measurement Quantity
Item
blood pressure more than 180/100mmhg at rest (3 consecutive measures).
boolean
C0005824 (UMLS CUI [1,1])
C0443144 (UMLS CUI [1,2])
C0242485 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0443144 (UMLS CUI [1,2])
C0242485 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])